LEUCOVORIN Drug Patent Profile
✉ Email this page to a colleague
When do Leucovorin patents expire, and what generic alternatives are available?
Leucovorin is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Gland, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Fresenius Kabi Usa, Ingenus Pharms Llc, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, Xanodyne Pharm, Am Regent, Mylan Labs Ltd, Sagent Pharms, and Sagent Pharms Inc. and is included in forty-nine NDAs.
The generic ingredient in LEUCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Leucovorin
A generic version of LEUCOVORIN was approved as leucovorin calcium by HIKMA on September 14th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEUCOVORIN?
- What are the global sales for LEUCOVORIN?
- What is Average Wholesale Price for LEUCOVORIN?
Summary for LEUCOVORIN
| US Patents: | 0 |
| Applicants: | 24 |
| NDAs: | 49 |
| Drug Prices: | Drug price information for LEUCOVORIN |
| DailyMed Link: | LEUCOVORIN at DailyMed |
US Patents and Regulatory Information for LEUCOVORIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 040347-001 | Apr 25, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 072734-001 | Feb 22, 1993 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ingenus Pharms Llc | LEUCOVORIN CALCIUM | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210917-001 | Nov 23, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Leading | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 213929-002 | Oct 22, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 040258-001 | Feb 26, 1999 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |


